Application no. and date | 00959423.5 (espacenet) (Federated) (European Patent Register), 20000825 | Patent/reg. no. and date | DK/EP 1210115, 20090805 | Publication date | 20020605 | Priority no. and date | US 151018 P, 19990827, US 213822 P, 20000623 | EP pub. no. and date |
EP 1210115 20020605 | Effective date | | Applicant/owner | GENENTECH, INC., 1 DNA Way South San Francisco, CA 94080-4990, US | Applicant ref. no. | 153287 | Inventor | SHAK, Steven, 1133 Cambridge Road
Burlingame, CA 94010, US, BAUGHMAN, Sharon, Ann, 1050 Driftwood Lane
Ventura, CA 93001, US | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/32 (2006.01) | Title | Doseringer til behandling med anti-ErB2-antistoffer | Int. application no. | US2000023391 | Int. publication no. | WO2001015730 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|